In a recent public announcement, the Food and Drug Administration (FDA) revealed that Zen Principle’s Moringa Capsules are undergoing a voluntary recall due to potential contamination with salmonella, a bacteria that can pose significant health risks to consumers. This precautionary measure was initiated on July 19 by Relay Peak Research LLC, operating under the Zen Principle brand, based in Incline Village, Nevada.
:max_bytes(150000):strip_icc():format(jpeg)/Zen-Principle-brand-Moringa-Capsules-072326-1-866ac256b2cb4f88b4ed0bc2035caf2a.jpg)
The recall is specifically targeting 180-count bottles of Zen Principle Moringa Capsules, which were distributed through popular online platforms including Amazon, eBay, and Etsy between December 2025 and July 2026. The affected lot is identified under the number A6FF4, and the capsules are marked with the expiration date of November 2028, which can be found printed on the bottom of the packaging.
Salmonella infections can lead to severe complications, particularly in vulnerable populations, such as young children, the elderly, and individuals with compromised immune systems. The FDA noted that while most healthy individuals might experience symptoms like fever, diarrhoea (sometimes bloody), nausea, vomiting, and abdominal pain when infected, salmonella can sometimes lead to more serious conditions, including arterial infections, endocarditis, and arthritis.
Zen Principle’s decision to recall their product was prompted after the company learned from its ingredient supplier that routine FDA testing of the moringa leaf powder—an ingredient used in the manufacturing of the capsules—tested positive for salmonella. Following this notification, the firm promptly halted all sales and distribution of the affected lot and is cooperating with the FDA in its investigation.
Consumers who have purchased the recalled capsules are strongly advised to cease using the product immediately. The FDA encourages the disposal of the capsules to prevent any potential health risks. A full refund is being offered to all affected customers. For assistance, consumers can contact Zen Principle directly at 775-451-6171, available from 9 a.m. to 5 p.m. Pacific Time, or via email at info@zenprinciple.com.
Currently, the recall applies only to the specified lot of Moringa Capsules. The FDA confirmed that no other Zen Principle products are implicated in this situation, and as of now, there have been no reports of illnesses associated with the consumption of these capsules.
Zen Principle has stated its commitment to ensuring product safety and is taking the necessary steps to inform all customers of the issue. The company has pledged to work closely with the FDA throughout the duration of the recall process.
This incident underscores the importance of regular testing and safety protocols within the dietary supplement industry, especially given the potential health implications associated with bacterial contamination. Consumers are urged to remain vigilant and keep informed about product recalls that may affect their health and well-being.
As the situation develops, further updates regarding the recall and any findings from ongoing investigations will be closely monitored. It serves as a reminder for consumers to be proactive in checking the authenticity and safety of health supplements they intend to use.